These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 25713207)
1. Induction of human UDP-Glucuronosyltransferase 2B7 gene expression by cytotoxic anticancer drugs in liver cancer HepG2 cells. Hu DG; Mackenzie PI; Lu L; Meech R; McKinnon RA Drug Metab Dispos; 2015 May; 43(5):660-8. PubMed ID: 25713207 [TBL] [Abstract][Full Text] [Related]
2. Epirubicin upregulates UDP glucuronosyltransferase 2B7 expression in liver cancer cells via the p53 pathway. Hu DG; Rogers A; Mackenzie PI Mol Pharmacol; 2014 Jun; 85(6):887-97. PubMed ID: 24682467 [TBL] [Abstract][Full Text] [Related]
3. Expression of UGT2B7 is driven by two mutually exclusive promoters and alternative splicing in human tissues: changes from prenatal life to adulthood and in kidney cancer. Ménard V; Lévesque E; Chen S; Eap O; Joy MS; Ekström L; Rane A; Guillemette C Pharmacogenet Genomics; 2013 Dec; 23(12):684-96. PubMed ID: 24128937 [TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms in the 5'-flanking region of human UDP-glucuronosyltransferase 2B7 affect the Nrf2-dependent transcriptional regulation. Nakamura A; Nakajima M; Higashi E; Yamanaka H; Yokoi T Pharmacogenet Genomics; 2008 Aug; 18(8):709-20. PubMed ID: 18622263 [TBL] [Abstract][Full Text] [Related]
5. The caudal-related homeodomain protein Cdx2 and hepatocyte nuclear factor 1alpha cooperatively regulate the UDP-glucuronosyltransferase 2B7 gene promoter. Gregory PA; Gardner-Stephen DA; Rogers A; Michael MZ; Mackenzie PI Pharmacogenet Genomics; 2006 Jul; 16(7):527-36. PubMed ID: 16788384 [TBL] [Abstract][Full Text] [Related]
6. Regulation of UDP-Glucuronosyltransferases UGT2B4 and UGT2B7 by MicroRNAs in Liver Cancer Cells. Wijayakumara DD; Mackenzie PI; McKinnon RA; Hu DG; Meech R J Pharmacol Exp Ther; 2017 Jun; 361(3):386-397. PubMed ID: 28389526 [TBL] [Abstract][Full Text] [Related]
7. Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7. Innocenti F; Iyer L; Ramírez J; Green MD; Ratain MJ Drug Metab Dispos; 2001 May; 29(5):686-92. PubMed ID: 11302935 [TBL] [Abstract][Full Text] [Related]
8. Screening of anticancer drugs for chemoembolization of hepatocellular carcinoma. Boulin M; Guiu S; Chauffert B; Aho S; Cercueil JP; Ghiringhelli F; Krause D; Fagnoni P; Hillon P; Bedenne L; Guiu B Anticancer Drugs; 2011 Sep; 22(8):741-8. PubMed ID: 21487286 [TBL] [Abstract][Full Text] [Related]
9. Octamer transcription factor-1 enhances hepatic nuclear factor-1alpha-mediated activation of the human UDP glucuronosyltransferase 2B7 promoter. Ishii Y; Hansen AJ; Mackenzie PI Mol Pharmacol; 2000 May; 57(5):940-7. PubMed ID: 10779377 [TBL] [Abstract][Full Text] [Related]
10. Modulation of the UGT2B7 enzyme activity by C-terminally truncated proteins derived from alternative splicing. Ménard V; Collin P; Margaillan G; Guillemette C Drug Metab Dispos; 2013 Dec; 41(12):2197-205. PubMed ID: 24088326 [TBL] [Abstract][Full Text] [Related]
11. Homo- and hetero-dimerization of human UDP-glucuronosyltransferase 2B7 (UGT2B7) wild type and its allelic variants affect zidovudine glucuronidation activity. Yuan L; Qian S; Xiao Y; Sun H; Zeng S Biochem Pharmacol; 2015 May; 95(1):58-70. PubMed ID: 25770680 [TBL] [Abstract][Full Text] [Related]
12. Polymorphisms and haplotypes of the UDP-glucuronosyltransferase 2B7 gene promoter. Hu DG; Meech R; Lu L; McKinnon RA; Mackenzie PI Drug Metab Dispos; 2014 May; 42(5):854-62. PubMed ID: 24561451 [TBL] [Abstract][Full Text] [Related]
13. Single nucleotide polymorphism discovery and functional assessment of variation in the UDP-glucuronosyltransferase 2B7 gene. Innocenti F; Liu W; Fackenthal D; Ramírez J; Chen P; Ye X; Wu X; Zhang W; Mirkov S; Das S; Cook E; Ratain MJ Pharmacogenet Genomics; 2008 Aug; 18(8):683-97. PubMed ID: 18622261 [TBL] [Abstract][Full Text] [Related]
14. Resveratrol in human hepatoma HepG2 cells: metabolism and inducibility of detoxifying enzymes. Lançon A; Hanet N; Jannin B; Delmas D; Heydel JM; Lizard G; Chagnon MC; Artur Y; Latruffe N Drug Metab Dispos; 2007 May; 35(5):699-703. PubMed ID: 17287390 [TBL] [Abstract][Full Text] [Related]
15. Effect of aflatoxin B1 on UDP-glucuronosyltransferase mRNA expression in HepG2 cells. Hanioka N; Nonaka Y; Saito K; Negishi T; Okamoto K; Kataoka H; Narimatsu S Chemosphere; 2012 Oct; 89(5):526-9. PubMed ID: 22749127 [TBL] [Abstract][Full Text] [Related]
16. Mitomycin C and doxorubicin elicit conflicting signals by causing accumulation of cyclin E prior to p21WAF1/CIP1 elevation in human hepatocellular carcinoma cells. Choi SY; Shen YN; Woo SR; Yun M; Park JE; Ju YJ; Jeong J; Shin HJ; Joo HY; Park ER; Lee JK; Kim SH; Cho MH; Kong IS; Lee KH Int J Oncol; 2012 Jan; 40(1):277-86. PubMed ID: 21887464 [TBL] [Abstract][Full Text] [Related]
17. Simvastatin induces growth inhibition and apoptosis in HepG2 and Huh7 hepatocellular carcinoma cells via upregulation of Notch1 expression. Huang X; Ma J; Xu J; Su Q; Zhao J Mol Med Rep; 2015 Mar; 11(3):2334-40. PubMed ID: 25412322 [TBL] [Abstract][Full Text] [Related]
18. Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity. Liu X; Yue P; Khuri FR; Sun SY Cancer Res; 2005 Oct; 65(20):9169-75. PubMed ID: 16230375 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of 3'-azido-3'-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism. Court MH; Krishnaswamy S; Hao Q; Duan SX; Patten CJ; Von Moltke LL; Greenblatt DJ Drug Metab Dispos; 2003 Sep; 31(9):1125-33. PubMed ID: 12920168 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus X protein inhibits p53-mediated upregulation of mitofusin-2 in hepatocellular carcinoma cells. Wang W; Zhou D; Wei J; Wu Z; Cheng X; Sun Q; Xie H; Zhou L; Zheng S Biochem Biophys Res Commun; 2012 May; 421(2):355-60. PubMed ID: 22510407 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]